Clinical Trial Update: Vestibular Versus Sublingual Route of AIT Tablets [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing vestibular versus sublingual routes of allergen immunotherapy tablets for hypersensitivity conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity

Snippet

Sponsor: Clinique Spécialisée en Allergies de la Capitale | Conditions: Hypersensitivity | Phase 4 | Status: COMPLETED